NZ510536A - Increasing intestinal absorption of fats by increasing the amount of lysophosphatidylcholine in the intestine through therapeutic oral administration - Google Patents

Increasing intestinal absorption of fats by increasing the amount of lysophosphatidylcholine in the intestine through therapeutic oral administration

Info

Publication number
NZ510536A
NZ510536A NZ510536A NZ51053699A NZ510536A NZ 510536 A NZ510536 A NZ 510536A NZ 510536 A NZ510536 A NZ 510536A NZ 51053699 A NZ51053699 A NZ 51053699A NZ 510536 A NZ510536 A NZ 510536A
Authority
NZ
New Zealand
Prior art keywords
lysophosphatidylcholine
fatty acid
composition
monoglyceride
isolated complex
Prior art date
Application number
NZ510536A
Other languages
English (en)
Inventor
David W Yesair
Original Assignee
Biomolecular Products Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomolecular Products Inc filed Critical Biomolecular Products Inc
Publication of NZ510536A publication Critical patent/NZ510536A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y301/00—Hydrolases acting on ester bonds (3.1)
    • C12Y301/01—Carboxylic ester hydrolases (3.1.1)
    • C12Y301/01004—Phospholipase A2 (3.1.1.4)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NZ510536A 1998-09-08 1999-09-07 Increasing intestinal absorption of fats by increasing the amount of lysophosphatidylcholine in the intestine through therapeutic oral administration NZ510536A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9943098P 1998-09-08 1998-09-08
PCT/US1999/020427 WO2000013689A1 (en) 1998-09-08 1999-09-07 Methods and compositions for increasing intestinal absorption of fats

Publications (1)

Publication Number Publication Date
NZ510536A true NZ510536A (en) 2003-07-25

Family

ID=22274976

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ510536A NZ510536A (en) 1998-09-08 1999-09-07 Increasing intestinal absorption of fats by increasing the amount of lysophosphatidylcholine in the intestine through therapeutic oral administration

Country Status (13)

Country Link
US (1) US6426069B1 (cg-RX-API-DMAC10.html)
EP (1) EP1119360B1 (cg-RX-API-DMAC10.html)
JP (1) JP4700193B2 (cg-RX-API-DMAC10.html)
CN (1) CN1321089A (cg-RX-API-DMAC10.html)
AT (1) ATE347371T1 (cg-RX-API-DMAC10.html)
AU (1) AU771901B2 (cg-RX-API-DMAC10.html)
CA (1) CA2343116C (cg-RX-API-DMAC10.html)
DE (1) DE69934325T2 (cg-RX-API-DMAC10.html)
IL (2) IL141801A0 (cg-RX-API-DMAC10.html)
NO (1) NO20011173L (cg-RX-API-DMAC10.html)
NZ (1) NZ510536A (cg-RX-API-DMAC10.html)
WO (1) WO2000013689A1 (cg-RX-API-DMAC10.html)
ZA (1) ZA200102268B (cg-RX-API-DMAC10.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1434593B1 (en) * 2001-10-11 2017-03-29 Biomolecular Products, Inc. MODIFICATIONS OF SOLID 3-sn-PHOSPHOGLYCERIDES
EP1350435B1 (en) 2002-04-05 2010-12-22 Societe Des Produits Nestle S.A. Compositions and methods for promoting lipid assimilation in pets
DE10217555A1 (de) * 2002-04-19 2004-02-19 Degussa Bioactives Deutschland Gmbh Physiologisch verträgliche, Phospholipid-haltige, stabile und harte Matrix
ES2581184T3 (es) * 2003-01-31 2016-09-01 Childrens Hospital Los Angeles Composiciones orales de fenretinida que tienen mayor biodisponibilidad y métodos de uso de las mismas
US7758884B2 (en) * 2005-01-28 2010-07-20 Kemin Industries, Inc. Formulation for increasing the deposition of dietary carotenoids in eggs
EP1688049A1 (de) * 2005-02-03 2006-08-09 findusFit Sportdiätetika GmbH Diätetisches Lebensmittel
FR2918846B1 (fr) * 2007-07-20 2013-07-26 Isl Innovation Sante Lipides Composition alimentaire pour ameliorer la digestibilite des lipides alimentaires
CN103179990B (zh) * 2010-10-22 2015-02-04 学校法人福冈大学 应用了对胃上皮性肿瘤(腺瘤、胃癌)的诊断有用的白色不透明物质的内窥镜观察法及诊断能力改善组合物
CA2817957C (en) * 2010-11-15 2016-05-10 Texas Tech University Substance for increasing the production of a specific acyl-chain dihydroceramide(s) for improving the effectiveness of cancer treatments
AU2019342421B2 (en) 2018-09-21 2024-09-05 Société des Produits Nestlé S.A. Compositions and methods for treatment of exocrine pancreatic insufficiency (EPI)
CN118416114A (zh) * 2024-01-12 2024-08-02 小藻科技(安吉)有限公司 一种促进脂肪酸吸收及跨越血脑屏障的微藻提取物及其组合物的应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4874795A (en) * 1985-04-02 1989-10-17 Yesair David W Composition for delivery of orally administered drugs and other substances
US4849132A (en) 1986-05-16 1989-07-18 Asahi Denka Kogyo Kabushiki Kaisha Surfactant composition having improved functions
US5571517A (en) 1990-08-13 1996-11-05 Yesair; David W. Mixed lipid-bicarbonate colloidal particles for delivering drugs or calories
ES2071332T3 (es) 1990-08-13 1995-06-16 David W Yesair Particulas coloidales de lipidos mixtos-bicarbonato para administrar farmacos o calorias.
US5302400A (en) * 1992-06-22 1994-04-12 Digestive Care Inc. Preparation of gastric acid-resistant microspheres containing digestive enzymes and buffered-bile acids
JPH08143469A (ja) * 1994-11-14 1996-06-04 Amano Pharmaceut Co Ltd 膵外分泌機能不全症治療剤
EP0835097B1 (en) * 1995-06-06 2001-08-29 Biomolecular Products, Inc. Mixed lipid-bicarbonate colloidal particles for delivering drugs or calories
US5716814A (en) 1996-02-02 1998-02-10 Biomolecular Products, Inc. Methods for making lysophosphatidylcholine
WO1998010776A1 (en) * 1996-09-11 1998-03-19 Shanahan Prendergast Elizabeth Therapeutic formulations containing venom or venom anti-serum either alone or in combination for the therapeutic prophylaxis and therapy of neoplasms

Also Published As

Publication number Publication date
NO20011173D0 (no) 2001-03-07
CA2343116A1 (en) 2000-03-16
JP2002524417A (ja) 2002-08-06
JP4700193B2 (ja) 2011-06-15
WO2000013689A1 (en) 2000-03-16
EP1119360B1 (en) 2006-12-06
EP1119360A4 (en) 2003-06-04
DE69934325T2 (de) 2007-07-05
AU771901B2 (en) 2004-04-08
US6426069B1 (en) 2002-07-30
ATE347371T1 (de) 2006-12-15
AU5705299A (en) 2000-03-27
IL141801A0 (en) 2002-03-10
DE69934325D1 (de) 2007-01-18
NO20011173L (no) 2001-05-08
IL141801A (en) 2009-02-11
EP1119360A1 (en) 2001-08-01
CN1321089A (zh) 2001-11-07
ZA200102268B (en) 2001-09-19
CA2343116C (en) 2008-11-18

Similar Documents

Publication Publication Date Title
CN100418519C (zh) 用于增强认知能力的含有花生四烯酸或其与二十二碳六烯酸的组合的组合物
JP2021035648A (ja) 経腸栄養補給デバイスおよび関連する使用の方法
EP3361885B1 (en) Infant formula with special lipid architecture for promoting healthy growth
CA2343116C (en) Methods and compositions for increasing intestinal absorption of fats
WO2008149177A2 (en) Marine lipid compositions and uses thereof
JPH08193028A (ja) ヘリコバクターの阻害
US20050154064A1 (en) Dietary and other compositions, compounds, and methods for reducing body fat, controlling appetite, and modulating fatty acid metabolism
JP3467794B2 (ja) 学習能向上剤
JP2011502950A (ja) 栄養センサー
US20060041017A1 (en) Synergistic conjugated linoleic acid (CLA) and carnitine combination
US20080058286A1 (en) Novel applications of omega-3 rich phospholipids
CN100408031C (zh) 含七碳脂肪酸甘油三酯的营养补充剂或药物制剂
WO2001049282A2 (en) Therapeutic preparations of highly unsaturated fatty acids
EP1106181A1 (en) Nutritional compositions for preventing or treating hyperlipoproteinemia
Takahashi et al. Marine by-product phospholipids as booster of medicinal compounds
US7842679B2 (en) Phospholipid derivatives of DHA and methods for treating respiratory failure using the same
Tamargo et al. Pharmacokinetics and safety profile of omega-3 polyunsaturated fatty acids
US7592370B2 (en) Fatty acid treatment for cardiac patients
Chen et al. Docosahexaenoic acid-containing phospholipids and triglycerides based nutritional supplements
US20030032672A1 (en) Method for preparing a conjugated linoleic acid-containing structured lipid and use of the same
JPS62111926A (ja) コリン作働性神経系活性化剤
Staggers Lipid digestion and absorption in the suckling rat.
HK40080058A (en) Parenteral nutrition formulation and methods of preparation thereof
JPWO2000009138A1 (ja) 高リポタンパク血症予防用または治療用の栄養組成物
HK1138205A (en) Nutritional supplement or pharmaceutical preparation comprising triglycerides with seven-carbon fatty acid

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)
EXPY Patent expired